✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

Towards biomarker-driven cancer immunotherapy: the rising of a protein phosphatase regulator · NabkaNews

← Back to headlines

Towards biomarker-driven cancer immunotherapy: the rising of a protein phosphatase regulator

Nature·Oct 14

This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.

Full coverage

Protein Kinase Inhibitors Market Size, Share & Outlook to 2035

Business Research Insights·3d ago

Biomarker-Driven Strategies for Drug Development

Inside Precision Medicine·Feb 16

T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology

Frontiers·Jan 12

Precision Oncology Market Size, Share | Industry Report [2034]

Fortune Business Insights·Jun 29

Why biomarkers are critical in modern drug discovery and trials

News-Medical·Mar 9

Beyond the Genome: Exploring New Frontiers in NSCLC Management

OncLive·Nov 15

Precision immunotherapies take aim at secondary immune checkpoints

Next-Generation Cancer Diagnostics Market Size Worth USD 38.36 Billion by 2034

BioSpace·Nov 18

View original report at Nature ↗